VIA Pharmaceuticals, Inc. (Nasdaq: VIAP) received a deficiency letter from The NASDAQ Stock Market notifying the Company of its failure ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE